Home›Companies›Biotech & Pharma›Everest Biolabs

Everest Biolabs, Inc.

Makes instruments and kits for researchers studying small particles released by cells.

Updated Nov 11, 2026·Latest SEC filing Mar 11, 2026·Suggest an edit

About Everest Biolabs

Everest Biolabs is a private company based in Waltham, Massachusetts, incorporated in 2024 in Delaware. It has reported $4,350,000 raised in one offering on Form D since March 2026. Its chief executive is George Daaboul.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 25, 2026Mar 11, 2026$4,350,000of $5.6M target7$621KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Everest Biolabs's Form D filed Mar 11, 2026.

David Freedman
David Freedman
COO, President, Co-Founder & Board Director
Paul Meister
Paul Meister
Board Director
George Daaboul
George Daaboul
CEO, Co-Founder & Board Director
David Walt
David Walt
Co-Founder & Board Director

Sources

  1. SECEverest Biolabs, Inc. filing history
  2. CompanyAbout Everest Biolabs
  3. CompanyContact Everest Biolabs
  4. PressEverest Biolabs product launch